Among the metabolites that showed a greater than 20% case-control difference, we also examined differences among hypothesized predictors of breast cancer risk, including differences by age at blood draw, the number of affected first-degree relatives (Table 3), ER status, and PR status (Table 4). Here, ESR1 is linked to breast cancer.